NRIX
Nurix TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
NRIX vs peer average
56/100
NRIX vs. peer average (B vs. B)
Grade spread
A 1 · B 6 · C 3 · D 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CLDX is the first available peer comparator.
Celldex is the closest market-cap clinical-stage biotech comparator in the candidate set: valuation is also heavily event-driven by trial updates and regulatory path clarity rather than current product revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NRIX
Nurix Therapeutics
CLDX
Celldex Therapeutics
Grade
B
C
Momentum
73
45
Value
41
41
Sentiment
66
61
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs CLDX
NRIX / CLDX
Grade Position
In line
NRIX vs. peer average (B vs. B)
56/100
Momentum
73
NRIXValue
41
NRIXSentiment
66
NRIXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NRIX
CLDX is the first peer returned for this comparison set.